The role of CD4+CD25+FOXP3+ regulatory T cells (Tregs) in acute lymphoblastic leukemia development has been linked to a higher immunosuppressive activity compared to the Tregs of healthy subjects, leading to the inhibition of anti-tumor immunity [20,25]. The gene discussed is CD4; the disease is acute lymphoblastic leukemia.